$2.38T
Total marketcap
$39.7B
Total volume
BTC 50.61%     ETH 14.79%
Dominance

2cureX AB (publ) 2QE.F Stock

0.02 EUR {{ price }} -16.923077% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
581.09K EUR
LOW - HIGH [24H]
0.02 - 0.02 EUR
VOLUME [24H]
1.1K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.16 EUR

2cureX AB (publ) Price Chart

2cureX AB (publ) 2QE.F Financial and Trading Overview

2cureX AB (publ) stock price 0.02 EUR
Previous Close 0.41 EUR
Open 0.41 EUR
Bid 0.42 EUR x 0
Ask 0.45 EUR x 0
Day's Range 0.41 - 0.41 EUR
52 Week Range 0.41 - 1.12 EUR
Volume 1K EUR
Avg. Volume 302 EUR
Market Cap 7.25M EUR
Beta (5Y Monthly) 0.777777
PE Ratio (TTM) N/A
EPS (TTM) -0.16 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

2QE.F Valuation Measures

Enterprise Value 7.2M EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

2cureX AB (publ) Stock Price History

Beta (5Y Monthly) 0.777777
52-Week Change -60.82%
S&P500 52-Week Change 20.43%
52 Week High 1.12 EUR
52 Week Low 0.41 EUR
50-Day Moving Average 0.55 EUR
200-Day Moving Average 0.7 EUR

2QE.F Share Statistics

Avg. Volume (3 month) 302 EUR
Avg. Daily Volume (10-Days) 300 EUR
Shares Outstanding 17.6M
Float 10.91M
Short Ratio N/A
% Held by Insiders 55.65%
% Held by Institutions 0.49%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -37.53%
Return on Equity (ttm) -57.50%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 82.89%
Gross Profit (ttm) 3.37M EUR
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.15
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 12.961
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of 2cureX AB (publ)

Country Germany
State N/A
City Copenhagen
Address Fruebjergvej 3
ZIP 2100
Phone 45 22 11 53 99
Website https://www.2curex.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 14

2cureX AB (publ) operates as a medtech company in Europe. The company's principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.

Q&A For 2cureX AB (publ) Stock

What is a current 2QE.F stock price?

2cureX AB (publ) 2QE.F stock price today per share is 0.02 EUR.

How to purchase 2cureX AB (publ) stock?

You can buy 2QE.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for 2cureX AB (publ)?

The stock symbol or ticker of 2cureX AB (publ) is 2QE.F.

Which industry does the 2cureX AB (publ) company belong to?

The 2cureX AB (publ) industry is Biotechnology.

How many shares does 2cureX AB (publ) have in circulation?

The max supply of 2cureX AB (publ) shares is 26.9M.

What is 2cureX AB (publ) Price to Earnings Ratio (PE Ratio)?

2cureX AB (publ) PE Ratio is now.

What was 2cureX AB (publ) earnings per share over the trailing 12 months (TTM)?

2cureX AB (publ) EPS is -0.16 EUR over the trailing 12 months.

Which sector does the 2cureX AB (publ) company belong to?

The 2cureX AB (publ) sector is Healthcare.